Emily Tsao
Toronto, ON M5S1A1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Activation of a nongenetic AHR-ELMSAN1 axis optimizes BET-targeting therapy and suppresses leukemia stem cells in preclinical models.
Journal: Science translational medicine
Published: August 06, 2025
Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS.
Journal: Blood
Published: July 14, 2025
Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS.
Journal: Blood
Published: July 14, 2025
Transplanted human photoreceptors transfer cytoplasmic material but not to the recipient mouse retina.
Journal: Stem cell research & therapy
Published: November 24, 2023
Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicity.
Journal: Haematologica
Published: August 05, 2022
In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target.
Journal: Blood cancer discovery
Published: May 17, 2022
Treponema pallidum Disrupts VE-Cadherin Intercellular Junctions and Traverses Endothelial Barriers Using a Cholesterol-Dependent Mechanism.
Journal: Frontiers in microbiology
Published: April 06, 2021
Identification of the Neuroinvasive Pathogen Host Target, LamR, as an Endothelial Receptor for the Treponema pallidum Adhesin Tp0751.
Journal: mSphere
Published: April 03, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026